Olema Pharmaceuticals, Inc. Common Stock
Symbol: OLMA (NASDAQ)
8.21
▼ (-1.72%) -0.144
Company Description:
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Key Stats
- Today's Open: $8.24
- Today's High: $8.515
- Today's Low: $8.03
- Today's Volume: 316.57K
- Yesterday Close: $8.35
- Yesterday High: $8.865
- Yesterday Low: $8.32
- Yesterday Volume: 930.96K
- Last Min Volume: 1.15K
- Last Min High: $8.21
- Last Min Low: $8.208
- Last Min VWAP: $8.20909
Company Profile
- Name: Olema Pharmaceuticals, Inc. Common Stock
- Website: https://www.olema.com
- Listed Date: 2020-11-19
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001750284
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $573.10M
- Round Lot: 100
- Outstanding Shares: 68.63M
- Asset Type: CS
RECENT FILINGS FOR OLMA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-18 | 4 | View |
| 2025-09-18 | 144 | View |
| 2025-09-16 | 144 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on OLMA